MELOXICAM TABLETS
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency awarded contract SPE2DP26F9991 to DMS Pharmaceutical Group Inc on September 16, 2026, for the procurement of Meloxicam Tablets. This award is a delivery order issued under the broader commercial items contract SPE2DX25D9900, which was established by the DLA Troop Support Medical Supply Chain FSB on April 2, 2025. The specific order for the tablets, identified by NSN 6505015413243 and PR 7018376810, has a total value of 135.00 dollars and specifies delivery to Fort Bragg, North Carolina. This procurement is designated as a set-aside for Small Disadvantaged Women-Owned businesses. The overarching base administrative contract incorporates FAR Part 12 clauses and serves as a replacement for contract SPE2DX25D9383 under the primary base contract SPE2DX25D9000.
General Info
Contract Value
$135Place of Performance
Not specifiedSet-Aside
Awardee
DMS PHARMACEUTICAL GROUP INCAward Issued Date
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
